ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI

September 13, 1996

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

Clinton Proposes Increase For Science And Technology.

February 4, 2000

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014